{
    "clinical_study": {
        "@rank": "95848", 
        "acronym": "BEET-PAH", 
        "arm_group": [
            {
                "arm_group_label": "Nitrate rich beetroot juice", 
                "arm_group_type": "Active Comparator", 
                "description": "Eligible subjects will be randomised, in a double-blind crossover design, to receive treatment with either nitrate rich beetroot juice (70 ml containing approximately 4 mmol nitrate - active comparator)or nitrate depleted beetroot juice (70 ml - placebo) twice daily for 7 days (treatment period 1) followed by a 7 day washout period followed by treatment twice daily with the active comparator or placebo depending on initial treatment for another 7 days (treatment period 2) ."
            }, 
            {
                "arm_group_label": "Nitrate depleted beetroot juice", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Eligible subjects will be randomised, in a double-blind crossover design, to receive treatment with either nitrate rich beetroot juice (70 ml containing approximately 4 mmol nitrate - active comparator)or nitrate depleted beetroot juice (70 ml - placebo)twice daily for 7 days (treatment period 1) followed by a 7 day washout period followed by treatment twice daily with the active comparator or placebo depending on initial treatment for another 7 days (treatment period 2) ."
            }
        ], 
        "brief_summary": {
            "textblock": "The study is a single center randomised, double-blind, placebo-controlled crossover study to\n      assess the effects of beetroot juice in patients with pulmonary arterial hypertension."
        }, 
        "brief_title": "BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Pulmonary Arterial Hypertension", 
        "condition_browse": {
            "mesh_term": [
                "Hypertension, Pulmonary", 
                "Hypertension"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  PAH (pulmonary arterial hypertension)\n\n          -  WHO functional class II-III\n\n        Exclusion Criteria:\n\n          -  WHO functional class I or IV\n\n          -  pregnancy\n\n          -  known intolerance or allergy to beetroot\n\n          -  treatment with Allopurinol\n\n          -  treatment with Iloprost (inhaled)\n\n          -  systolic bloodpressure < 95 mmHg\n\n          -  diabetes mellitus type 2"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02000856", 
            "org_study_id": "BEET-PAH"
        }, 
        "intervention": {
            "arm_group_label": [
                "Nitrate rich beetroot juice", 
                "Nitrate depleted beetroot juice"
            ], 
            "intervention_name": "Beetroot juice", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Uppsala", 
                    "country": "Sweden"
                }, 
                "name": "Uppsala University Hospital"
            }, 
            "investigator": {
                "last_name": "Gerhard Wikstr\u00f6m, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension", 
        "overall_contact": {
            "email": "gerhard.wikstrom@medsci.uu.se", 
            "last_name": "Gerhard Wikstr\u00f6m, MD, PhD"
        }, 
        "overall_official": {
            "affiliation": "Uppsala University and Uppsala University Hospital", 
            "last_name": "Gerhard Wikstr\u00f6m, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Uppsala Regional Ethical Review Board (Sweden)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in VO2 submax and or VO2 max", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02000856"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in 6MWT", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "Change in WHO functional class", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "description": "Change in; pulmonary artery systolic pressure (PASP), ventricular diastolic function, systolic right and left ventricular function, right and left atrial/ventricular dimensions will be calculated", 
                "measure": "Change in echocardiographic parameters", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "Change in exhaled NO", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "Change in systemic bloodpressure", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "description": "Change in the following biochemical variables will be calculated; ADMA, SDMA, Arginine, Citrulline, Ornithine, uric acid, nitrate, nitrite", 
                "measure": "Change in metabolic pathways involved in nitric oxide production and regulation", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "Change in NT-pro-BNP", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }
        ], 
        "source": "Uppsala University", 
        "sponsors": {
            "collaborator": {
                "agency": "Department of Physiology and Pharmacology Karolinska Institute Stockholm", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Uppsala University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}